Factor V Leiden Prevalence in Venous Thromboembolism Patients
- 1 June 1997
- Vol. 111 (6) , 1603-1606
- https://doi.org/10.1378/chest.111.6.1603
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Resistance to activated protein C in an unselected population of patients with pulmonary embolismThe Lancet, 1996
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor VNew England Journal of Medicine, 1994
- Evaluation of activated protein C resistance in stored plasmaThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Activated protein C resistance in deep-vein thrombosisThe Lancet, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Value of the Ventilation/Perfusion Scan in Acute Pulmonary EmbolismJAMA, 1990